Ireland MF, Funk GD, Bellingham MC. Muscarinic acetylcholine receptors enhance neonatal mouse hypoglossal motoneuron excitability in vitro. J Appl Physiol 113: 1024 -1039, 2012; doi:10.1152/japplphysiol.00699.2011.-In brain stem slices from neonatal (postnatal days 0 -4) CD-1 mice, muscarinic ACh receptors (MAChRs) increased rhythmic inspiratory-related and tonic hypoglossal nerve discharge and depolarized single hypoglossal motoneurons (HMs) via an inward current without changing input resistance. These responses were blocked by the MAChR antagonist 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (4-DAMP; 100 nM). MAChRs shifted voltage-dependent activation of the hyperpolarization-activated cation current to more positive levels. MAChRs increased the HM repetitive firing rate and decreased rheobase, with both effects being blocked by 4-DAMP. Muscarinic agonists reduced the afterhyperpolarization of single action potentials (APs), suggesting that small-conductance Ca 2ϩ -dependent K ϩ current inhibition increased the HM firing rate. Muscarinic agonists also reduced the AP amplitude and slowed its time course, suggesting that MAChRs inhibited voltage-gated Na ϩ channels. To compare muscarinic excitation of single HMs to muscarinic excitatory effects on motor output in thicker brain stem slices requiring higher extracellular K ϩ for rhythmic activity, we tested the effects of muscarinic agonists on single HM excitability in high-K ϩ artificial cerebrospinal fluid (aCSF). In high-K ϩ aCSF, muscarinic agonists still depolarized HMs and altered AP size and shape, as in standard aCSF, but did not increase the steady-state firing rate, decrease afterhyperpolarization, or alter threshold potential. These results indicate that the basic cellular response of HMs to muscarinic receptors is excitatory, via a number of distinct mechanisms, and that this excitatory response will be largely preserved in rhythmically active brain stem slices.
MAChRs shifted voltage-dependent activation of the hyperpolarization-activated cation current to more positive levels. MAChRs increased the HM repetitive firing rate and decreased rheobase, with both effects being blocked by 4-DAMP. Muscarinic agonists reduced the afterhyperpolarization of single action potentials (APs), suggesting that small-conductance Ca 2ϩ -dependent K ϩ current inhibition increased the HM firing rate. Muscarinic agonists also reduced the AP amplitude and slowed its time course, suggesting that MAChRs inhibited voltage-gated Na ϩ channels. To compare muscarinic excitation of single HMs to muscarinic excitatory effects on motor output in thicker brain stem slices requiring higher extracellular K ϩ for rhythmic activity, we tested the effects of muscarinic agonists on single HM excitability in high-K ϩ artificial cerebrospinal fluid (aCSF). In high-K ϩ aCSF, muscarinic agonists still depolarized HMs and altered AP size and shape, as in standard aCSF, but did not increase the steady-state firing rate, decrease afterhyperpolarization, or alter threshold potential. These results indicate that the basic cellular response of HMs to muscarinic receptors is excitatory, via a number of distinct mechanisms, and that this excitatory response will be largely preserved in rhythmically active brain stem slices. acetylcholine; motoneuron; excitation; action potential; afterhyperpolarization; hyperpolarization-activated cation current; repetitive firing; calcium-dependent potassium current; voltage-gated sodium current HYPOGLOSSAL MOTONEURONS (HMs) innervate the intrinsic and most extrinsic muscles of the tongue (14) and play a key role in the maintenance of upper airway patency during respiration as well as taking part in the coordinated contractions involved in swallowing, suckling, vocalization, and other oral behaviors (27, 79) . HM activity is significantly modified during the sleep-wake cycle, with high levels of activity during wakefulness, decreased activity in slow-wave sleep, and lowest activity in rapid eye movement (REM) sleep (40) . These state-dependent changes in HM activity are likely due to state-dependent changes in the release of several neuromodulators, including serotonin, norepinephrine, ACh, and neuropeptides (11, 12, 38) . Understanding the neurochemical regulation of HM excitability is important, as decreases in HM activity may underlie conditions such as obstructive sleep apnea (11, 27) . Cholinergic modulation of HMs may be particularly important, as apneic episodes occur frequently in REM sleep (27) , a state in which ACh release is high and aminergic neuromodulator release is low (11, 27) . The ability of acetylcholinesterase inhibitors to alleviate obstructive sleep apnea has led to the hypothesis that a cholinergic deficit may contribute to this condition (12, 36, 89) .
HMs receive cholinergic inputs from both medullary and pontine sources (7, 12, 26, 78, 98) , which act on cholinergic receptors (71) . In particular, muscarinic ACh receptors (MAChRs) are highly expressed in the rodent HM nucleus (66, 75) as well as a variety of individual MAChR gene products (49, 101) and receptor subtypes (48, 65) . In in vitro rat brain stem slices, MAChRs depress both excitatory (10) and inhibitory synaptic inputs (65) to HMs by presynaptic mechanisms but excite HMs by postsynaptic suppression of the action potential (AP) afterhyperpolarization (AHP) and membrane depolarization (46) . In rhythmically active brain stem slices, bath application of MAChR agonists slows the frequency of bursting and increases the size of rhythmic respiratory motor burst activity (11) . These are due, at least in part, to MAChR actions on the respiratory central rhythm generator (81, 82) and local activation of MAChRs within the HM nucleus, which increases both inspiratory and tonic HM activity (11, 51) . In contrast, injection of MAChR agonists into the HM nucleus in anesthetized rats in vivo usually depresses rhythmic HM activity (50) . This divergence of HM responses to MAChR activation under in vitro and in vivo conditions raises questions about the fundamental postsynaptic effects of MAChR activation on single HMs in isolation compared with HMs receiving rhythmic inspiratory synaptic drive as well as the underlying ionic mechanisms.
To investigate the muscarinic responses of HMs, we recorded the effects of MAChR activation on neonatal mouse HM excitability in both rhythmic and nonrhythmic in vitro brain stem slices. In rhythmically active slices, local application of muscarine increased integrated HM nerve burst amplitude and area without changing burst frequency. In nonrhythmic slices, we found that bath-applied muscarinic agonists significantly enhanced single HM excitability by a combination of membrane depolarization, increased firing rate associated with suppression of the AHP, and decreased threshold for AP firing. As the bathing fluids for rhythmic and nonrhythmic slices differed significantly in their K ϩ and Ca 2ϩ concentrations, relevant ionic mechanisms influenced by extracellular K ϩ and Ca 2ϩ levels, such as resting "leak" K conductance (109) or Ca 2ϩ -dependent K ϩ conductances, may be differentially modulated by MAChRs in these two conditions. To directly compare our single HM responses with those underlying increased hypoglossal nerve activity in rhythmically active brain stem slices, which are often recorded in solutions with high extracellular K ϩ levels for sustained rhythmic activity, we also first applied high-K ϩ extracellular solution to nonrhythmic slices and then activated MAChRs. We found that HM excitability was still enhanced by membrane depolarization and decreased threshold for firing, but without increased firing rate or suppression of the AHP. These results indicate that the cellular postsynaptic response of HMs to MAChR activation is fundamentally excitatory and suggest that in vivo depression of HM activity after local MAChR activation is likely due to a suppression of other excitatory or neurochemical inputs to HMs.
METHODS
Recordings were made from transverse brain stem slices containing the HM nucleus prepared from 0-to 4-day-old Swiss CD-1 mice (n ϭ 43) of either sex. Animal care and handling was approved by the animal ethics committees of University of Queensland or University of Auckland and were in accordance with university and national guidelines.
Brain slice preparations. Nonrhythmic slices were prepared as previously described (10, 42) . Animals of Ͻ4 days old were anesthetized by hypothermia or with pentobarbitone sodium (4 days old, 100 mg/kg by intraperitoneal injection) and then decapitated. The brain stem was rapidly removed, and 200-m-thick transverse slices were made with a vibratome (D.S.K Microslicer DTK-1000, Ted Pella) in ice-cold cutting solution containing (in mM) 130 NaCl, 26 NaHCO 3, 10 glucose, 3 KCl, 1.25 NaH2P04, 5 MgCl2, and 1 CaCl2 gassed with 95% O2-5% CO2. Slices were incubated in the same solution at 35°C for 1 h and then transferred to normal recording solution containing (in mM) 130 NaCl, 26 NaHCO 3, 10 glucose, 3 KCl, 1.25 NaH2P04, 1 MgCl2, and 2 CaCl2 gassed with 95% O2-5% CO2 (pH 7.4); this solution approximates the ionic composition of cerebrospinal fluid, except for the higher glucose concentration, and is commonly called artificial cerebrospinal fluid (aCSF) (69) . Slices were maintained at room temperature (20 -22°C) for up to 6 h after being sliced. For recordings, slices were superfused (1-2 ml/min) with the same aCSF or with high-K ϩ aCSF containing (in mM) 120 NaCl, 9 KCl, 26 NaHCO3, 20 glucose, 1.25 NaH2P04, 1 MgCl2, and 1 CaCl2; both perfusing solutions were gassed with 95% O2-5% CO2 (pH 7.4) and were at room temperature (20 -22°C) .
Techniques for the preparation of rhythmically active brain slices (32) have been described in detail elsewhere. Briefly, mice were anaesthetized with diethylether and decerebrated, and the brain stemspinal cord isolated in a 15-ml dissection chamber containing (in mM) 120 NaCl, 3 KCl, 1 CaCl 2, 2 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, and 20 D-glucose (pH 7.45) bubbled with 95% O2-5% CO2 at room temperature. The brain stem-spinal cord was pinned to a wax chuck and sectioned using a vibratome (Pelco-101, Ted Pella). Serial sections (100 -200 m) were cut in the rostrocaudal direction and examined for neuroanatomic landmarks until the compact division of the nucleus ambiguus and the rostral border of the inferior olive were observed, whereupon a single 600-m section was cut. This slice extended from the rostral margin of the pre-Bötzinger complex (preBötC) to the obex and contained the preBötC, rostroventral respiratory group, XII motor nuclei, and rostral XII nerve rootlets. The slice was pinned caudal surface up in a recording chamber (10-ml volume) and superfused with 26 -27°C aCSF at a flow rate of 20 ml/min. The concentration of K ϩ in the aCSF was raised from 3 to 9 mM at least 30 min before the start of data collection. Medullary slices from neonatal Swiss CD-1 mice and Sprague-Dawley rats generate a stable rhythm in 3 mM K ϩ that then decays (76, 77) . The majority of protocols in this study involved multiple interventions and therefore required slices that produced stable inspiratory-related rhythm for extended periods. Therefore, the K ϩ concentration in aCSF was raised from 3 to 9 mM to produce prolonged, stable rhythm (33, 76, 77) .
Recording of XII nerve activity. Bilateral extracellular recordings of XII nerve activity were performed using suction electrodes with internal tip diameters ranging from 40 to 80 m. Recordings were amplified (50,000 times), band-pass filtered (0.1-3 kHz), full-wave rectified, and integrated (time constant: 50 ms). The output of the integrator was displayed on a storage oscilloscope (Tektronix 5111, Beaverton, OR), recorded on a chart recorder (Gould Instruments 2400S, Valley View, OH), and, along with raw data, stored via pulse code modulation on VCR cassette (Vetter 402).
Analysis of XII nerve output. Rectified, integrated nerve recordings were analyzed for inspiratory burst frequency as well as ipsilateral and contralateral XII nerve inspiratory burst amplitudes using a customwritten LabView (National Instruments, Austin, TX) acquisition and analysis program (written by Dr. Dean Robinson). Burst amplitude was quantified (in arbitrary voltage units) as the distance from baseline to the peak of the integrated burst envelope; burst area was similarly quantified as the area between the baseline and the integrated burst envelope. In cases where drug application was associated with an increase in tonic nerve discharge and a shift in the baseline, burst amplitude and area were calculated by subtracting the baseline shift. While some of the baseline shift may represent tonic activation of respiratory motoneurons, baseline correction was chosen to reduce the possibility of overestimating the potentiating actions of MAChRs on inspiratory burst parameters. Contralateral nerve activity was recorded to monitor the degree of drug diffusion to the contralateral motor nucleus. Responses to local application of 10 M muscarine onto the XII nucleus were exclusively unilateral. MAChR-mediated decreases in frequency, indicative of muscarine diffusion to rhythm-generating regions of the slice in the ventrolateral medulla (74), were not usually observed with local application of muscarine to the XII nucleus. The magnitude of the responses was determined by comparing control burst amplitude (averaged over 2 min before drug application) with the highest value of a 30-s moving average recorded during the first minute after the onset of drug application.
All drugs applied in the superfusing aCSF were by mixture of stock solutions (typically of 1,000ϫ higher concentration) into aCSF to obtain the final concentration stated. Stock solvents, such as DMSO, were thus at Յ0.1% final concentration; vehicle alone at this level did not alter HM excitability. Drugs were applied locally by pressure injection of a droplet from a multibarreled micropipette positioned over the surface of the HM nucleus; the drug was dissolved directly into high-K ϩ aCSF to obtain the final concentration stated. While the true concentration achieved by local drug application is unknown, responses equivalent to those evoked by bath application required ϳ10-fold higher concentration (Fig. 1B,1) .
Single HM recordings in nonrhythmic slices. Whole cell patchclamp recordings were made from visually identified HMs (n ϭ 48) using infrared videomicroscopy (Zeiss Axioskop FS, Oberkochen, Germany; Sony Exwave HAD SSC M383CE video camera, Sony, Japan; model 605 video contrast enhancer, Colorado Video) as previously described (10) . Patch electrodes (3-5 M⍀) were pulled from borosilicate glass capillaries (Vitrex, Modulohm) and filled with an intracellular solution containing (in mM) 135 K methylsulfate, 8 NaCl, 10 HEPES, 2 Mg2ATP, and 0.3 Tris-GTP (pH 7.3). Patch electrodes were not Sylgard coated or fire polished; a high-resistance seal (Ͼ1 G⍀) with the HM membrane was always obtained before the whole cell patch-clamp mode was entered. All recordings were in current clamp except where noted; acceptable HM recordings had a resting membrane potential of Ϫ50 mV or more negative, whole cell capacitance Ͼ 20 pS, and APs that overshot 0 mV and showed repetitive firing in response to depolarizing current steps. Recorded membrane potentials were not adjusted for a liquid junction potential of Ϫ8 mV. Voltage signals were low-pass filtered at 5 kHz with a Multiclamp 700A amplifier (Axon Instruments, Foster City, CA), sampled at 20 kHz (Digidata 1200A, Axon Instruments), and then stored on a personal computer. Series resistance was Ͻ20 M⍀ and was compensated by 40 -80% in voltage-clamp recordings.
Electrophysiological data protocols and analysis. Whole cell patch-clamp data were recorded and measured using pCLAMP 9.0 and 10.0 software, respectively (Axon Instruments). Where required, a constant holding current was injected in the presence of high-K ϩ aCSF and/or drugs to achieve similar membrane potentials to those in control aCSF recordings. Repetitive firing was evoked by rectangular depolarizing current steps (10 -900 pA) of 500 to 1,000 ms in duration. Firing-current (F-I) plots of the number and instantaneous frequency of APs (detected by a threshold crossing algorithm in pCLAMP 10.0) during repetitive firing were related to the size of the current step added to any constant holding current. Steady-state repetitive firing was defined as the mean firing frequency of all APs after the third AP in response to an individual current step, as the first three APs typically showed a rapid decrease in firing frequency. AP threshold current (rheobase) was extrapolated from linear regression of the relationship between AP number and current; the extrapolated rheobase current was calculated as that required to evoke 0.5 APs/s, and only HMs with a linear regression coefficient (r 2 ) of Ͼ0.9 were used for this measurement. Single APs were evoked by brief (2-5 ms) suprathreshold depolarizing current steps. Single AP and AHP amplitudes were measured relative to AP threshold, as determined by visual inspection as the time point immediately before the initial positive inflection of the AP rise during the current step. Action half-width and maximal rate of rise and decay were measured relative to the threshold potential. Input resistance was calculated from the slope of the linear relationship between membrane potential and total membrane current for the final 50 ms of subthreshold current steps. Statistical analysis of measurements was done using Excel (Microsoft, Redmond, WA). All data are given as means Ϯ SE and were compared statistically with a Student's two-tailed paired t-test or one-sample t-test with two tails ), and 1 mM (3) caused a progressive increase in the amplitude and area of integrated nerve bursts without change in nerve burst frequency. An increase in baseline noise, indicating tonic HM firing, is seen in 2 and 3. A brief bath application (horizontal bar) of muscarine (10 M) caused increased nerve burst amplitude and area and decreased nerve burst frequency and tonic baseline activity (4) . Left, continuous recording of nerve bursts before and after muscarine application; right, averaged integrated nerve bursts (n ϭ 10 bursts) before local injection and at the peak of responses. The vertical scale bars are 1 arbitrary unit (AU); the horizontal scale bars are 100 s for left graphs and 250 ms for right graphs. B: doseresponse curve for HM nerve responses to local and bath application of muscarine. 1, mean nerve burst area (normalized to control levels) was significantly increased with the application of 1 M (n ϭ 2) and 10 M (n ϭ 9) muscarine in the bath or 10 M (n ϭ 6), 100 M (n ϭ 15), and 1 mM (n ϭ 16) muscarine locally but not to 100 nM (n ϭ 2) muscarine in the bath or 1 M (n ϭ 2) locally; responses to bath application were approximately equivalent to a local application at a 10-fold higher concentration of muscarine. 2, mean nerve burst frequency normalized to control levels shows that bath-applied muscarine decreased burst frequency at 10 M, whereas local application at any concentration did not reduce frequency. All tests were one-sample two-tailed t-tests compared with a value of 1 (normalized control level).
where noted, with statistical significance accepted at P Ͻ 0.05. All statistical tests were done with Prism 5.0 (Graphpad).
Chemicals. All chemicals used in electrophysiological experiments were obtained from Sigma except for K methylsulfate, which was from ICN Biochemicals.
RESULTS
MAChRs increase hypoglossal nerve burst size but decrease burst frequency. Local application of muscarine (10 M to 1 mM) to the ipsilateral HM nucleus evoked significant increases in the amplitude and area of ipsilateral hypoglossal nerve bursts, as shown in Fig. 1A,1-3 . These effects increased in a dose-dependent manner (Fig. 1B,1) , with the mean area increasing to 1.48 Ϯ 0.14 (10 M, n ϭ 5), 2.03 Ϯ 0.22 (100 M, n ϭ 14), and 2.48 Ϯ 0.36 (1 mM, n ϭ 14) of the baseline value; dose-dependent increases in tonic hypoglossal nerve activity were also notable. Burst frequency was not significantly changed ( Fig. 1B,2) , and locally applied muscarine did not alter contralateral XII nerve activity.
Bath application of muscarine (1 M to 10 M) also significantly increased hypoglossal nerve burst amplitude and area bilaterally, with the mean normalized burst area increasing to 1.36 Ϯ 0.025 (1 M, n ϭ 2) and 1.48 Ϯ 0.18 (10 M, n ϭ 9; Fig These results also illustrate the complex effects of MAChR activation, even within a significantly reduced in vitro rhythmic preparation; effects on HM firing may be directly mediated by the activation of HM MAChRs or via indirect effects of changes in synaptic drive to HMs from the respiratory rhythm generator. We therefore sought to elucidate the direct effects of MAChR activation by recording membrane responses of single HMs in nonrhythmic slices.
Baseline electrophysiological properties of HMs. All HMs accepted for recording and analysis had a stable resting membrane potential in normal aCSF negative to Ϫ50 mV before the injection of any holding current. The mean resting membrane potential in normal aCSF was Ϫ59.5 Ϯ 0.7 mV (n ϭ 48), the mean whole cell capacitance was 49 Ϯ 5 pF (n ϭ 48), and the mean input resistance was 225 Ϯ 19 M⍀ (n ϭ 38). The mean AP amplitude relative to baseline membrane potential before the application of depolarizing current steps was 84 Ϯ 2 mV, and the mean AP overshoot was 25 Ϯ 3 mV.
Activation of MAChRs depolarizes HMs. In normal aCSF, bath application of MAChR-selective agonists caused significant HM membrane depolarization (Fig. 2) . Muscarine (10 M) caused a mean depolarization of 3.7 mV (from Ϫ56.8 Ϯ 0.9 to Ϫ53.2 Ϯ 1.6 mV, n ϭ 12, P ϭ 0.02; Fig. 2 , A and B), whereas oxotremorine (OxoT; 10 M) caused a mean depolarization of 3.9 mV (from Ϫ61.4 Ϯ 3.0 to Ϫ57.6 Ϯ 3.2, n ϭ 4, P ϭ 0.03). As shown in Fig. 2 , C and D, bath application of the MAChR-selective antagonist 4-DAMP (100 nM) had no significant mean effect on membrane potential alone (Ϫ56.5 Ϯ 1.6 to Ϫ55.2 Ϯ 1.7 mV, n ϭ 7) but blocked membrane depolarization by muscarine (Ϫ55.7 Ϯ 1.5 to Ϫ54.8 Ϯ 1.6 mV, n ϭ 4), indicating that muscarine acted by activation of MAChRs. Additionally, bath application of muscarine in the presence of OxoT did not cause further significant depolarization (Ϫ57.9 Ϯ 5 to Ϫ56.6 Ϯ 4.3 mV, n ϭ 3; Fig. 2C ), indicating that both muscarinic agonists act via common MAChRs.
The mechanism underlying muscarinic depolarization was tested by bath application of OxoT to HMs voltage clamped at Ϫ60 mV, which evoked a mean net inward current of Ϫ29 pA (from 51 Ϯ 16 to 22 Ϯ 14 pA, n ϭ 6, P ϭ 0.003; Fig. 2 , E and F). However, this inward current coupled with muscarinic membrane depolarization was not associated with significant changes in HM input resistance (Fig. 2G) , as neither muscarine (238 Ϯ 34 to 251 Ϯ 38 M⍀, n ϭ 12, P ϭ 0.49) nor OxoT (265 Ϯ 55 to 280 Ϯ 59 M⍀, n ϭ 7, P ϭ 0.33) altered HM input resistance; likewise, 4-DAMP alone did not significantly change HM input resistance (322 Ϯ 52 to 325 Ϯ 60 M⍀, n ϭ 6, P ϭ 0.93).
Activation of MAChRs positively modulates the hyperpolarization-activated cationic current. Taken together, the responses above suggest that muscarinic membrane depolarization is likely due to positive modulation of a depolarizing voltage-dependent membrane current largely inactivated at resting membrane potential, such as the hyperpolarizationactivated cationic current (I H ) (9) . To directly test this hypothesis, we recorded I H evoked by a family of negative voltage steps from a holding potential of Ϫ60 mV in four HMs. In control conditions, the slowly activating inward current elicited by these voltage steps progressively increased in magnitude with more negative voltages (as shown in the control trace in Fig. 3A ). Bath application of muscarine (10 M) increased the size of this current for a given voltage step (Fig. 3A) . Each negative voltage step was ended by a constant step to Ϫ80 mV to elicit a tail current, whose relative amplitude indicated the fraction of maximal I H activated by the preceding negative voltage step (9) . The voltage-dependent activation of I H was estimated by nonlinear regression fitting of the Boltzmann equation to the normalized tail current amplitude plotted against step voltage (Fig. 3B) . Muscarine significantly positively shifted the half-activation potential for I H (Fig. 3C ) from a mean of Ϫ116 Ϯ 3 to Ϫ111 Ϯ 3 mV (P ϭ 0.048 by paired t-test) without altering the slope of the Boltzmann equation (mean slope of Ϫ15 Ϯ 0.8 and Ϫ14 Ϯ 0.6 for control and muscarine treatment, respectively; Fig. 3D) . I H is a depolarizing current that automatically inactivates at depolarized membrane potential, i.e., when membrane hyperpolarization activates I H , membrane potential will depolarize (due to activated I H ) until a potential is reached at which I H is no longer active. This means the hyperpolarizing leak K ϩ conductance, which predominates at resting membrane potential, is opposed by the depolarizing influence of I H . Any positive shift in the voltagedependent activation of I H will therefore lead to a more positive membrane potential (in the absence of any change in the leak K ϩ conductance, which we have established by showing that there is no change in instantaneous input resistance).
Muscarinic membrane depolarization is unaltered in high-K
ϩ aCSF. Our results demonstrated that direct activation of HM muscarinic receptors depolarizes HMs in nonrhythmically active slices and also strongly enhances hypoglossal nerve rootlet activity in rhythmically active brain stem slices from neonatal mice (11, 51) . While careful anatomic calibration of the rostrocaudal level and thickness of slices does allow the recording of rhythmic activity without requiring high extracellular K ϩ for periods that depend on slice thickness (76, 77) , in the majority of the published literature, stable long-term rhythmic activity is achieved by slice superfusion with aCSF containing a higher K ϩ concentration (7-9 mM) and lower Ca 2ϩ concentration (1 mM) compared with our aCSF (3 mM K ϩ and 2 mM Ca 2ϩ ). It is also clear that the responses of rhythmically active slices to neuromodulators may be different in high-K ϩ versus low-K ϩ conditions (6) . We therefore tested whether superfusion of thin nonrhythmic brain stem slices with high-K ϩ aCSF altered HM responses to MAChR activation. Changing the slice superfusate from normal to high-K ϩ aCSF caused a significant HM membrane depolarization of 11.4 mV (Fig. 4, A and B) , from a mean resting membrane potential of Ϫ62.1 Ϯ 0.9 to Ϫ50.6 Ϯ 0.9 mV (n ϭ 27, P Ͻ 0.0001), as expected due to a positive shift in K ϩ equilibrium potential (E K ) and similar to the membrane potential shift seen in rhythmically active HMs after a change from high-K ϩ aCSF to standard aCSF (109) . This depolarization was associated with a significant mean inward current of Ϫ48 pA (Fig. 2C) , from Ϫ5.4 Ϯ 5.8 to Ϫ53.4 Ϯ 7.6 pA (n ϭ 22, P Ͻ 0.0001), in HMs aCSF strongly depolarized HM resting membrane potential (P Յ 0.0001). After a readjustment of membrane potential to levels before high-K ϩ aCSF, bath application of OxoT (10 M) caused significant membrane depolarization (P Ͻ 0.0001). B: example of membrane depolarization with high-K ϩ aCSF application (bottom solid line) and further depolarization with concurrent application of OxoT (top solid line) and recovery to below control levels (dashed line) after washout to normal aCSF. Blank intervals at around 400 and 800 s occurred when other test were carried out, interrupting the continuous recording of membrane potential. C: high-K ϩ aCSF generates an inward current in HMs voltage clamped at Ϫ60 mV (P Ͻ 0.0001), and the subsequent application of OxoT in high-K ϩ aCSF still generated an inward current (P ϭ 0.0004). D: application of high-K ϩ aCSF significantly increased HM input resistance (P ϭ 0.03), but OxoT in high-K ϩ aCSF did not significantly change HM input resistance. NS, not significant.
voltage clamped at Ϫ60 mV and was also associated with a significant increase in HM input resistance (Fig. 4D ) of 45 M⍀, from 175 Ϯ 26 to 220 Ϯ 38 M⍀ (n ϭ 13, P ϭ 0.03). After a readjustment of membrane potential to levels approximating those in normal aCSF by injection of a constant holding current (mean constant current injection of 46 Ϯ 9 pA), bath application of OxoT in high-K ϩ aCSF still caused a highly significant membrane depolarization of 3.1 mV (Fig. 4,  A and B) , from Ϫ59.9 Ϯ 0.9 to Ϫ56.8 Ϯ 1.0 mV (n ϭ 19, P Ͻ 0.0001); only 1 of 19 HMs did not depolarize with OxoT application. As for OxoT application in normal aCSF, OxoT application in high-K ϩ aCSF elicited a mean inward current of Ϫ32.8 pA (Fig. 4C) Fig. 4D ). As these changes elicited by OxoT in high-K ϩ ACSF were almost identical to those elicited in normal aCSF, these data provide further evidence that inhibition of K ϩ -permeable channels open at rest (13, 90, 91) does not play a significant role in muscarinic responses in HMs.
Activation of MAChRs enhances HM firing by increasing F-I slope and decreasing rheobase. In normal aCSF, injection of long (0.4 -0.8 s) depolarizing current steps consistently evoked repetitive AP firing (Fig. 5, G and H) . The number of APs and firing rate typically increased with increased step size, until membrane depolarization during the current step reached high levels (greater than Ϫ20 mV; Fig. 5A ), at which level firing was sometimes intermittent or absent during the latter portion of the current step. In normal aCSF, the instantaneous firing rate rapidly declined to approximately steady-state levels within four APs.
In normal aCSF, bath application of muscarine significantly increased the slope of the F-I relationship (Fig. 5, A, B , and G) from 0.14 Ϯ 0.032 to 0.18 Ϯ 0.037 Hz/pA (n ϭ 10, P ϭ 0.046) and also significantly decreased extrapolated rheobase current (Fig. 5C ) by Ϫ32 Ϯ 12 pA (n ϭ 9, P ϭ 0.03). Bath application of 4-DAMP (100 nM) did not alter the F-I slope (control slope: 0.13 Ϯ 0.26 Hz/pA and 4-DAMP slope: 0.14 Ϯ 0.27 Hz/pA, n ϭ 7, P ϭ 0.19; Fig. 5D , E, and H) or rheobase current (mean change of 10 Ϯ 7.1 pA, n ϭ 7, P ϭ 0.2 by one-sample t-test; Fig. 5F ), indicating endogenous release of ACh did not produce tonic excitation of HMs through the activation of postsynaptic MAChRs (10, 82, 84) . Application of muscarine after 4-DAMP did not alter the F-I slope (control slope of 0.12 Ϯ 0.037, compared with 0.16 Ϯ 0.015 Hz/pA, n ϭ 4, P ϭ 0.12; Fig. 5, D and H) or rheobase current (mean change of 5.5 Ϯ 5.8 pA, n ϭ 4, P ϭ 0.42 by one-sample t-test; Fig. 5F ), indicating that muscarine acted through MAChRs to increase F-I slope and decrease rheobase.
Application of high-K ϩ ACSF alone increased HM firing (Fig. 6, A, B, and D) . High-K ϩ aCSF significantly increased the F-I slope from 0.12 Ϯ 0.034 to 0.15 Ϯ 0.042 Hz/pA (n ϭ 15, P ϭ 0.006) and significantly decreased rheobase by Ϫ36 Ϯ 7.7 pA (n ϭ 15, P ϭ 0.0003 by one-sample t-test; Fig. 6C ). In high-K ϩ aCSF, the addition of OxoT (10 M) did not increase the F-I slope further (Fig. 6, A, B, and D) , from 0.18 Ϯ 0.052 to 0.18 Ϯ 0.064 Hz/pA (n ϭ 13, P ϭ 0.89), but did still significantly decrease rheobase by Ϫ86 Ϯ 29 pA (n ϭ 13, P ϭ 0.011 by one-sample t-test; see Fig. 6C ). The lack of effect of OxoT on the F-I slope under high-K ϩ conditions suggests that high extracellular K ϩ significantly reduced the mechanism underlying the muscarinic changes in F-I slope, implying a K ϩ -dependent mechanism. However, as OxoT still evoked a reduction in rheobase current in high K ϩ , this suggests that rheobase reduction by MAChRs occurred via a different mechanism uninfluenced by extracellular K ϩ levels.
Activation of MAChRs reduces AP AHP in normal but not in high-K
ϩ aCSF. Increased F-I slope is associated with a shorter interval between successive APs, and a decrease in the size or duration of the medium AHP after the AP is the most common mechanism underlying this response (18) , as HMs lack a slow AHP (95) . Activation of MAChRs clearly reduced the medium AHP in repetitively firing HMs (Fig. 5G) , as did increasing the extracellular K ϩ concentration (Fig. 6D) . We therefore investigated the effects of MAChR activation on single APs and their following medium AHP.
In normal aCSF, MAChR agonists significantly reduced both medium AHP amplitude (Fig. 7, A and B) and AHP decay time constant (Fig. 7, B and C) . Muscarine decreased medium AHP amplitude by 25%, from Ϫ22.2 Ϯ 1.3 to Ϫ16.5 Ϯ 1.2 mV (n ϭ 11, P Ͻ 0.0001); the AHP decay time constant also decreased significantly by 39%, from 153 Ϯ 14 to 93 Ϯ 8 ms (P ϭ 0.0004). These effects of muscarine on medium AHP amplitude and decay time constant were completely occluded by prior application of 4-DAMP (n ϭ 4), which also had no significant effects on medium AHP amplitude or decay time constant (Fig. 7 , A-C) alone (n ϭ 7). OxoT also significantly decreased medium AHP amplitude by 7%, from Ϫ27.6 Ϯ 2.5 to Ϫ25.7 Ϯ 2.7 mV (n ϭ 7, P ϭ 0.045); AHP decay time constant decreased significantly by 43%, from 114 Ϯ 21 to 65 Ϯ 7 ms (P ϭ 0.03). OxoT also occluded the effects of muscarine on medium AHP amplitude and decay time constant (n ϭ 2; data not shown), showing that these MAChR agonists acted through a common receptor. These data indicate that MAChR activation reduces both medium AHP amplitude and duration, thus shortening the interval between successive APs and increasing the HM firing rate. Previous work (46, 57, 95) has demonstrated that apamin completely abolishes the medium AHP in HMs and other motoneurons, showing that the medium AHP is exclusively due to the activation of apamin-sensitive Ca 2ϩ -dependent K ϩ channels. It is likely that postsynaptic MAChRs act to reduce the apamin-sensitive medium AHP current in mouse HMs, as previously shown for rat HMs (46) .
In addition to effects on the AHP, MAChR activation also altered AP amplitude, maximal rates of rise and decay, halfwidth, and threshold potential (Fig. 7, D-H) . Muscarine decreased AP amplitude by 11% (P ϭ 0.003; Table 1 and Fig. 7,  B and D) , slowed the maximal rise slope by 25% (P ϭ 0.0001; Table 1 and Fig. 7E ) and maximal decay slope by 24% (P ϭ 0.0002; Table 1 and Fig. 7E ), increased AP half-width by 18% (P ϭ 0.005; Table 1 and Fig. 7H ), and hyperpolarized AP threshold potential by Ϫ3 mV (P ϭ 0.015; Table 1 and Fig.  7F ). Effects of muscarine on these parameters were fully or partially blocked by prior application of 4-DAMP (see Table 1 for values); muscarine then significantly depolarized AP threshold potential by 2.8 mV (P ϭ 0.001), decreased AP amplitude by 6% (P ϭ 0.02), decreased maximal rise slope by 18% (P ϭ 0.005), but did not significantly change maximal decay slope or AP half-width. Alone, 4-DAMP also significantly depolarized AP threshold potential, decreased AP amplitude and maximal rise slope, and increased half-width (see Table 1 for values). OxoT had similar but smaller effects on some of these AP parameters (Table 1) ; AP amplitude decreased by 9% (P ϭ 0.08), and maximal rise slope decreased by 19% (P ϭ 0.02), but maximal decay slope, half-width, and AP threshold potential were not significantly altered.
A notable effect of changing from normal aCSF to high-K ϩ aCSF was a large reduction in medium AHP amplitude. The amplitude of the medium AHP after single APs significantly decreased by 34% (P Ͻ 0.0001; Table 1 and Fig. 8, A and B) ; the AHP decay time constant also significantly decreased by 31% (P ϭ 0.011; Table 1 and Fig. 8C ). Neither the AP amplitude nor the maximal rate of rise were altered by high-K ϩ aCSF (Table 1 and Fig. 8, D and E) , but AP threshold potential decreased by Ϫ3 mV (P ϭ 0.013; Table 1 and Fig. 8F ). Maximal decay slope decreased by 20% (P ϭ 0.0011; Table 1 and Fig. 8G ), and half-width increased by 21% (P ϭ 0.0015; Table 1 and Fig. 8H ). The effects of MAChR activation on APs were partially occluded in high-K ϩ aCSF. In high-K ϩ aCSF, OxoT did not significantly alter medium AHP amplitude (from Ϫ18 Ϯ 1.5 to Ϫ18 Ϯ 1.8 mV, n ϭ 15, P ϭ 0.9; Fig. 8, A and  B) or decay time constant (from 65 Ϯ 10 to 71 Ϯ 18 ms, n ϭ 10, P ϭ 0.6; Fig. 8C ). However, OxoT did significantly decrease AP amplitude by 9% (P ϭ 0.01; Fig. 8D ), maximal rise slope by 16% (P ϭ 0.001; Fig. 8E ), and decay slope by 14% (P ϭ 0.0002; Fig. 8G ) and increased half-width by 13% (P ϭ 0.0019; Fig. 6H ) without altering AP threshold potential (P ϭ 0.73; Fig. 8H ) in high-K ϩ aCSF.
DISCUSSION
These data indicate that direct activation of MAChRs of HMs elicits a fundamentally excitatory response due to multiple postsynaptic mechanisms. The main mechanisms underlying excitation are 1) membrane depolarization via a K ϩ -independent current that is inactive at resting membrane potential, 2) decreased medium AHP amplitude and duration due to a decrease in Ca 2ϩ -dependent K ϩ current, 3) hyperpolarization of AP threshold potential via a K ϩ -dependent mechanism, and 4) reduction of AP amplitude and increased duration via actions on voltage-gated Na ϩ channels. This excitation occurs in both normal aCSF and in aCSF containing high K ϩ levels, duplicating conditions frequently used to sustain rhythmic respiratory activity in rodent brain stem slices (87) . In high-K ϩ conditions, MAChR activation primarily acts to excite HMs through membrane depolarization alone, while all four mechanisms are likely to contribute to HM excitation in the normal brain environment.
Membrane depolarization is due to positive modulation of I H . Membrane depolarization of similar magnitude occurs in both normal aCSF and high-K ϩ aCSF after MAChR activation. This shows that muscarinic modulation of current through K ϩ channels is unlikely to contribute substantially to this depolarization, as a positive shift in E K will decrease ionic driving force, which should significantly reduce depolarization if this . Muscarinic receptors do not increase HM F-I slope but still decrease rheobase in high-K ϩ aCSF. A: mean F-I relationship for HMs in normal aCSF, after the change to high-K ϩ aCSF and during bath application of muscarine in high-K ϩ aCSF. Injected current was normalized to the minimal total current (step ϩ baseline holding current) required to evoke an AP in normal aCSF for each HM. B: F-I relationship slope values before and after high-K ϩ aCSF and after muscarine in high-K ϩ aCSF as determined by least-squares linear regression. F-I slope was significantly different in high-K ϩ aCSF (P ϭ 0.0057) but not significantly different after muscarine application. C: extrapolated rheobase values, determined from the least-squares linear regression equations, before and after high-K ϩ aCSF were significantly decreased (P ϭ 0.0003), and a further significant decrease occurred after muscarine (P ϭ 0.01). D: example of repetitive firing in normal aCSF (top trace), which was strongly increased by the change to high-K ϩ aCSF (top middle trace) and further increased with the addition of muscarine (bottom middle trace) evoked by a depolarizing current step (bottom trace).
were the case. This finding rules out muscarinic inhibition of K ϩ channels open at resting membrane potential (8, 63) , such as two-pore domain weakly inward rectifying K ϩ channelrelated acid-sensitive K ϩ channels (58) , which are known to contribute to HM resting membrane potential and are modulated by a wide range of neurotransmitter receptors (13, 91) . Our observation that depolarization due to MAChR activation did not change HM input resistance reinforces this conclusion.
The absence of any change in input resistance suggests that muscarinic membrane depolarization is due to positive modulation of a depolarizing current normally inactive at rest. The most likely candidate for this role is I H , which is present in HMs and other motoneurons (9) . I H is produced by expression of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel gene family (52) and is a mixed cationic inward current, which slowly activates with prolonged membrane hyperpolarization and thus acts to return membrane potential to resting levels, at which I H is typically minimally active (15, 35) . Positive shifts in the voltage-dependent activation of I H can be elicited by a variety of neurotransmitters, including ACh (25, 111), serotonin (85) , and norepinephrine (47, 56) . In rat HMs, expression of I H is developmentally the peak amplitude of the AP was significantly reduced by muscarine (P ϭ 0.00229) and by OxoT (P ϭ 0.08); however, amplitude was also significantly reduced by 4-DAMP (P ϭ 0.03) or by muscarine after 4-DAMP (P ϭ 0.02). E: the maximal rise slope of the AP was significantly reduced by muscarine (P ϭ 0.0001) and by OxoT (P ϭ 0.02); however, rise slope was also significantly reduced by 4-DAMP (P ϭ 0.004) or by muscarine after 4-DAMP (P ϭ 0.004). F: the threshold potential for triggering the AP was significantly hyperpolarized by muscarine (P ϭ 0.015) but not altered by OxoT (P ϭ 0.47); in contrast, the threshold potential was significantly depolarized by 4-DAMP (P ϭ 0.02) or by muscarine after 4-DAMP (P ϭ 0.001). G: the maximal decay slope of the AP was significantly reduced by muscarine (P ϭ 0.0002) but not by OxoT (P ϭ 0.34), 4-DAMP (P ϭ 0.26), or muscarine after 4-DAMP (P ϭ 0.10). H: the half-width of the AP was significantly increased by muscarine (P ϭ 0.005) and by 4-DAMP (P ϭ 0.01); however, half-width was not altered by OxoT (P ϭ 0.31) or by muscarine after 4-DAMP (P ϭ 0.052).
regulated, with low levels of I H in neonatal rat HMs (9) We note that our input resistance measurement used a brief (10 -20 ms) current or voltage step, which will only measure instantaneous input resistance due to current flow through ion channels open at resting membrane potential, of which I H will only comprise a small (1-2%) fraction. Our input resistance measurement will also be largely governed by somatic membrane responses and will be relatively insensitive to changes in dendritic membrane resistance. Examples of this insensitivity abound in the literature: for example, the membrane conductance of motoneurons rarely changes as they receive endogenous glutamatergic drive, which clearly opens channels and increases membrane conductance (71) . As I H expression varies along the somatodendritic axis, with lower I H expression at the soma and higher expression in dendrites (15), any change in I H conductance contributing to dendritic input resistance would be difficult to detect. Finally, we only measured HM input resistance under steady-state conditions, before MAChR activation and after muscarinic responses had stabilized. I H will be minimal under both conditions, and therefore changes in input resistance due to changes in voltage-dependent activation of I H would be absent.
Our interpretation is reinforced by recent evidence supporting a significant role of I H in setting resting membrane potential in HMs, which express both HCN1 and HCN2 genes (22) . HMs of HCN1 knockout mice had a resting membrane potential that was 8 mV more hyperpolarized than that of wild-type mice, and this hyperpolarization was associated with a Ϫ5-mV shift in the half-activation voltage level for I H activation (22), whereas nitric oxide-mediated enhancement of I H in HMs caused a 3-mV depolarization associated with a ϩ3-mV shift in the half-activation voltage level for I H activation (102) . These changes are consistent with our finding that a ϩ5-mV shift in I H half-activation voltage level was associated with a ϩ4-mV depolarization in HM resting membrane potential.
The mechanism connecting MAChR activation and positive modulation of I H is highly dependent on the intracellular signaling cascade activated by MAChRs: both direct enhancement of I H by increased cAMP levels (28, 99) mediated by M 2 /M 4 receptors and by hydrolysis of phosphoinositol breakdown-generated products mediated by M 1 /M 3 /M 5 receptors (67) are capable of positively shifting I H activation (15) . The ability of 4-DAMP at a relatively low concentration to block depolarization suggests the M 3 receptor as a possible candidate. However, although 4-DAMP is often considered to be an M 3 receptor-preferring antagonist, it binds to both M 1 and M 5 receptors with similar affinity and can antagonize other MAChRs at the concentration (100 nM) used here (29, 100) . Further pharmacological characterization of the MAChR involved in HM depolarization is therefore needed.
Increased repetitive firing is likely due to inhibition of small-conductance Ca 2ϩ
-activated K ϩ current. A reduction of HM medium AHP amplitude and decay time constant after MAChR action was present in normal aCSF but was absent in high-K ϩ aCSF and was blocked by 4-DAMP. The absence of increased F-I slope with MAChR activation after either 4-DAMP or high-K ϩ aCSF indicates that muscarinic medium AHP reduction is the primary mechanism causing the increased F-I slope. Spinal and cranial motoneuron AHPs do not have a slow AHP component, with the medium AHP component being the primary determinant of F-I slope (57, 95, 96) . Numerous studies (1, 21, 45, 46, 57, 60, 62, 95) of motoneurons (including HMs) in several species have established that the medium AHP is due to an apamin-sensitive small-conductance (SK) Ca 2ϩ -dependent K ϩ current, which is strongly reduced by MAChR activation (21, 24, 46, 62 
Values are means Ϯ SE. Amplitude measurements are relative to action potential (AP) threshold potential. Maximal rise and decay rates are from AP trajectory positive to AP threshold potential. AP half-width was measured at AP threshold potential ϩ 0.5 ϫ AP amplitude. 4-DAMP, 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide; OxoT, oxotremorine; aCSF, artificial cerebrospinal fluid. *P Ͻ 0.05; †P Ͻ 0.01; ‡P Ͻ 0.0001; §P ϭ 0.08 (by paired two-tailed t-test before and after values).
attached to the cytoplasmic terminus of SK channels, opening the SK channel (30) . Reduction of SK channel current may be indirectly achieved by reducing Ca 2ϩ influx through inhibition of voltage-gated Ca 2ϩ channels (17, 41, 73) or directly modulated via casein kinase 2-mediated phosphorylation of SK channels, which both decreases the Ca 2ϩ sensitivity of calmodulin and speeds SK channel inactivation (2, 16, 34, 55 ). Both indirect and direct inhibition of SK channels may occur simultaneously. However, as MAChR activation both reduced medium AHP amplitude and decreased the AHP decay time constant, we favor direct modulation of SK channels as the more likely mechanism in HMs.
The effect of high-K ϩ aCSF alone was principally to reduce the medium AHP, thus occluding effects of MAChR activation. Medium AHP suppression in high-K ϩ aCSF was likely due to a reduced ionic driving force for K ϩ movement through ϩ and absence of any further change when OxoT was added. C: the decay time constant of the AHP, determined by leastsquares fitting of a single exponential function to the AHP decay, was significantly reduced by the change to high-K ϩ aCSF (P ϭ 0.012) but was not further reduced by OxoT (0.59). D: the peak amplitude of the AP was not altered by high-K ϩ aCSF (P ϭ 0.75) but was significantly reduced by OxoT in high-K ϩ aCSF (P ϭ 0.01). E: the maximal rise slope of the AP was not significantly altered by high-K ϩ aCSF (P ϭ 0.25) but was significantly reduced by OxoT in high-K ϩ aCSF (P ϭ 0.001). F: the threshold potential for triggering the AP was significantly hyperpolarized by high-K ϩ aCSF (P ϭ 0.013), and the addition of OxoT did not further hyperpolarize threshold (P ϭ 0.73). G: the maximal decay slope of the AP was significantly reduced by high-K ϩ aCSF (P ϭ 0.001) and was further reduced by the addition of OxoT (P ϭ 0.0002). H: the half-width of the AP was significantly increased by high-K ϩ aCSF (P ϭ 0.0015) and was further increased by the addition of OxoT (P ϭ 0.002). In contrast to the occlusion of MAChR effects on the medium AHP in high-K ϩ aCSF, other muscarinic effects on the AP (amplitude decrease, slower maximal rise rate, increased duration, and slower maximal repolarization rate) were largely preserved in high-K ϩ aCSF. These effects are quite similar to muscarinic effects on APs observed in CA1 hippocampal neurons (31); in hippocampal neurons, muscarinic effects on APs are Ca 2ϩ dependent and involve PKC activation and the phosphorylation of voltagegated Na ϩ channels (19, 23) . Modeling results have suggested that these effects decrease Na ϩ channel "availability" (20) , accounting for our observed decrease in AP amplitude and maximal rate of rise, as indirect reflections of Na ϩ channel availability (44, 68) . However, models in which Na ϩ channels simply become unavailable also predict a more depolarized AP threshold, in contrast to our observation of a more hyperpolarized AP threshold in HMs, which has also been reported for muscarinic modulation of oculomotor motoneuron firing (62) . Another effect of PKC is the induction of persistent Na ϩ channel activity (5, 64) , which is associated with a more negative AP threshold, together with decreased AP amplitude and rate of rise, as we have observed in HMs (5); we speculate that muscarinic stimulation of HMs shifts Na ϩ channels into a persistently active mode, which simultaneously decreases channel availability on depolarization.
Sources and effects of cholinergic modulation of HMs. Motoneurons, including HMs, receive significant numbers of cholinergic inputs, including large C-type synaptic boutons (7, 26, 37, 80, 93) , which appear early in the postnatal development of spinal motoneurons (105) . Recurrent motoneuron axon collaterals provide another source of cholinergic inputs to many cranial and spinal motoneurons, but these have not been reported in HMs (14, 97) . While the source of C boutons on spinal motoneurons has recently been revealed as a small group of cholinergic neurons located close to the central canal (110) , the source of cholinergic input to HMs remains poorly characterized. Cholinergic neurons in the pedunculopontine laterodorsal tegmental nuclei provide most cholinergic innervation of the brain stem and spinal cord (107) . They are retrogradely labeled from the HM nucleus (78, 108) , and are thus a likely source of cholinergic input. Hypoglossal premotor neurons in the intermediate reticular formation also express cholinergic neuron markers, providing a second possible source of cholinergic inputs (98) . Endogenous release of ACh in the HM nucleus occurs in both in vivo (86) and in vitro brain stem slices (10, 83) . It thus seems highly probable that cholinergic modulation of HMs by these inputs plays an important role in the regulation of HM activity.
In cats or rats, cholinergic stimulation of pedunculopontine regions containing cholinergic neurons evokes ACh release, respiratory depression (53) , and hypotonia of genioglossus electromyographic activity during a REM sleep-like state (39, 54) , suggesting that the release of ACh during REM sleep inhibits HM activity. This is consistent with the net inhibition of genioglossus activity seen when cholinergic or muscarinic agonists are microdialysed into the HM nucleus of anesthetized rats (50) but at odds with the excitatory responses of HMs seen at the single motoneuron level in our present results. One explanation is that development results in a fundamental change in the motoneuron response to MAChRs. However, maturation should increase muscarinic excitation, as muscarinic responses of adult motoneurons are enhanced compared with neonatal responses (21) , cholinergic synaptic inputs increase with maturation (105) , and adult motoneurons continue to express muscarinic enhancement of activity (45, 112) . Indeed, HMs from mice aged up to 4 wk show postsynaptic excitation after MAChR activation (M. F. Ireland and M. C. Bellingham, unpublished observations and Ref. 43) . Potent depression of the excitatory synaptic drive to HMs (88) by presynaptic M 2 muscarinic receptors (10) or inhibition of local premotor interneurons (106) may account for the muscarinic suppression of genioglossus activity after local microdialysis of muscarinic agonists (50) . Postsynaptic excitation of HMs by MAChRs may therefore be an important factor in opposing these depressive muscarinic effects during REM sleep.
The potential importance of cholinergic influences in regulating upper airway muscle activity is highlighted by studies of obstructive sleep apnea in humans, in which acetylcholinesterase inhibitors significantly reduced apneic episodes in both normal subjects (36, 89) and subjects with Alzheimer's disease (59) . It is also notable that Alzheimer's disease is associated with significant cholinergic impairment and is associated with a significantly higher prevalence of obstructive sleep apnea (3, 4) . While these studies do not reveal the sites of cholinergic action, if reduced muscarinic excitation of HMs contributes to the reduction in genioglossus activity seen in obstructive sleep apnea (27, 72, 103) , then inhibition of acetylcholinesterase could counteract this effect at the motor output level.
In summary, MAChRs excite neonatal HMs at the single neuron level via multiple postsynaptic mechanisms involving the regulation of resting membrane potential by I H and modulation of firing activity by voltage-gated Na ϩ and Ca 2ϩ -dependent K ϩ channels. These data will allow improved interpretation of cholinergic responses of HM activity in vivo and in rhythmically active in vitro preparations.
